US, CANADA AND BRAZIL INTRAGASTRIC BALLOONS MARKET FORECAST 2017-2023
KEY FINDINGS
The Intragastric Balloons are used for weight loss. They are saline-filled silicone balloons placed in the stomach for a span of months and limit the intake of food by giving the feeling of satiety. Americas include the US, Canada, Brazil, and rest of Americas and, its market was valued at $38.72 million in 2017 and is expected to reach $66.94 million by 2023, growing at a CAGR of 8.14% during the forecast period.
MARKET INSIGHTS
In 2017, Obesity has been estimated to cost the EU US$ 78.09 billion annually through healthcare costs and lost productivity. The US is one the countries that has the highest rate of obesity. Factors such as presence of a large obese population change in lifestyle, reduced hospital stay, short recovery time, and availability of low-priced Intragastric balloons is driving the growth of the market. However, limitations and adverse events of Intragastric balloons are likely to limit the adoption of this technology.
The Intragastric Balloons market was valued at US$136.64 million in 2017 and is expected to reach US$215.92 million by 2023 growing at a CAGR of 6.75% during the forecast period 2017-2023.
COMPETITIVE INSIGHTS
The Intragastric balloons market is highly competitive with presence of large, medium, and small players. Some of the major players in this market are Apollo Endoscopy Inc., Spatz FGIA Inc., Allurion Technologies Inc., ReShape Medical Inc., Hélioscopie SA, and Obalon Therapeutics Inc.
The Intragastric Balloons are used for weight loss. They are saline-filled silicone balloons placed in the stomach for a span of months and limit the intake of food by giving the feeling of satiety. Americas include the US, Canada, Brazil, and rest of Americas and, its market was valued at $38.72 million in 2017 and is expected to reach $66.94 million by 2023, growing at a CAGR of 8.14% during the forecast period.
MARKET INSIGHTS
In 2017, Obesity has been estimated to cost the EU US$ 78.09 billion annually through healthcare costs and lost productivity. The US is one the countries that has the highest rate of obesity. Factors such as presence of a large obese population change in lifestyle, reduced hospital stay, short recovery time, and availability of low-priced Intragastric balloons is driving the growth of the market. However, limitations and adverse events of Intragastric balloons are likely to limit the adoption of this technology.
The Intragastric Balloons market was valued at US$136.64 million in 2017 and is expected to reach US$215.92 million by 2023 growing at a CAGR of 6.75% during the forecast period 2017-2023.
COMPETITIVE INSIGHTS
The Intragastric balloons market is highly competitive with presence of large, medium, and small players. Some of the major players in this market are Apollo Endoscopy Inc., Spatz FGIA Inc., Allurion Technologies Inc., ReShape Medical Inc., Hélioscopie SA, and Obalon Therapeutics Inc.
1. RESEARCH SCOPE
1. STUDY GOALS
2. SCOPE OF THE MARKET STUDY
3. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
1. SOURCES OF DATA
2. MARKET SIZE ESTIMATION
3. DATA TRIANGULATION
4. ASSUMPTIONS
3. EXECUTIVE SUMMARY
4. INTRODUCTION
1. OBESITY
2. BMI RANGES
3. MORBID OBESITY
4. LOSING WEIGHT
5. HISTORY OF INTRAGASTRIC BALLOONS
6. RE-ENTRY OF INTRAGASTRIC BALLOONS
7. ADVANTAGES OF INTRAGASTRIC BALLOONS
8. COMPLICATIONS ASSOCIATED WITH INTRAGASTRIC BALLOONS
9. WHO IS NOT SUITABLE FOR PLACEMENT OF INTRAGASTRIC BALLOON
5. MARKET OVERVIEW
1. MARKET DRIVERS
2. MARKET RESTRAINTS
6. MARKET OPPORTUNITIES
7. AMERICA
1. US
2. CANADA
3. BRAZIL
4. REST OF AMERICA
8. KEY ANALYTICAL
1. VALUE CHAIN ANALYSIS
2. SUPPLY CHAIN ANALYSIS
3. KEY MARKET TRENDS
4. REGULATIONS IN EUROPE
5. STUDIES ON INTRAGASTRIC BALLOONING
9. COMPANY PROFILING
1. APOLLO ENDOSURGERY, INC.
2. ALLURION TECHNOLOGIES INC.
3. RESHAPE MEDICAL INC.
4. HÉLIOSCOPIE SA
5. SPATZ FGIA INC.
TABLE LIST
1. AMERICAS INTRAGASTRIC BALLOONS MARKET BY COUNTRY, 2017-2023, (IN $MILLION)
2. ESTIMATE OF BARIATRIC SURGERY NUMBERS IN THE US (2011-2015)
3. COST OF WEIGHT-LOSS SURGERIES IN THE US V/S INDIA IN $
4. CHANGES IN VOLUME OF DIFFERENT TYPES OF BARIATRIC PROCEDURES PERFORMED IN CANADIAN HOSPITALS (2006–2007 TO 2013–2014)
5. US INTRAGASTRIC BALLOONS MARKET, 2017-2023 (IN $MILLION)
6. CANADA INTRAGASTRIC BALLOONS MARKET, 2017-2023 (IN $MILLION)
7. BRAZIL INTRAGASTRIC BALLOONS MARKET, 2017-2023 (IN $MILLION)
8. REST OF AMERICAS INTRAGASTRIC BALLOONS MARKET, 2017-2023 (IN $MILLION)
FIGURE LIST
1. MARKET SIZE ESTIMATION
2. DATA TRIANGULATION
3. VALUE CHAIN ANALYSIS
4. AMERICAS MARKET SHARE, BY COUNTRY, 2017
5. US FOOD CONSUMPTION AS % OF CALORIES
6. PREVALENCE OF OBESITY IN THE US ADULTS AGED BETWEEN 20 TO
7. TRENDS IN OVERWEIGHT AND OBESITY RATES, BY EDUCATION LEVEL IN THE US
8. US INTRAGASTRIC BALLOONS MARKET, 2017-2023 (IN $MILLION)
9. PERCENTAGE OF OBESE POPULATION (SELF-REPORTED) IN CANADA 2014
10. TRENDS IN OVERWEIGHT AND OBESITY RATES, BY EDUCATION LEVEL IN CANADA
11. CANADA INTRAGASTRIC BALLOONS MARKET, 2017-2023 (IN $MILLION)
12. BRAZIL INTRAGASTRIC BALLOONS MARKET, 2017-2023 (IN $MILLION)
13. LATIN AMERICA: WORST OBESITY SCENARIO AMONG EMERGING COUNTRIES BY 2030
14. TRENDS IN OVERWEIGHT AND OBESITY RATES, BY EDUCATION LEVEL IN MEXICO
15. REST OF AMERICAS INTRAGASTRIC BALLOONS MARKET, 2017-2023 (IN $MILLION)
1. STUDY GOALS
2. SCOPE OF THE MARKET STUDY
3. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
1. SOURCES OF DATA
2. MARKET SIZE ESTIMATION
3. DATA TRIANGULATION
4. ASSUMPTIONS
3. EXECUTIVE SUMMARY
4. INTRODUCTION
1. OBESITY
2. BMI RANGES
3. MORBID OBESITY
4. LOSING WEIGHT
5. HISTORY OF INTRAGASTRIC BALLOONS
6. RE-ENTRY OF INTRAGASTRIC BALLOONS
7. ADVANTAGES OF INTRAGASTRIC BALLOONS
8. COMPLICATIONS ASSOCIATED WITH INTRAGASTRIC BALLOONS
9. WHO IS NOT SUITABLE FOR PLACEMENT OF INTRAGASTRIC BALLOON
5. MARKET OVERVIEW
1. MARKET DRIVERS
2. MARKET RESTRAINTS
6. MARKET OPPORTUNITIES
7. AMERICA
1. US
2. CANADA
3. BRAZIL
4. REST OF AMERICA
8. KEY ANALYTICAL
1. VALUE CHAIN ANALYSIS
2. SUPPLY CHAIN ANALYSIS
3. KEY MARKET TRENDS
4. REGULATIONS IN EUROPE
5. STUDIES ON INTRAGASTRIC BALLOONING
9. COMPANY PROFILING
1. APOLLO ENDOSURGERY, INC.
2. ALLURION TECHNOLOGIES INC.
3. RESHAPE MEDICAL INC.
4. HÉLIOSCOPIE SA
5. SPATZ FGIA INC.
TABLE LIST
1. AMERICAS INTRAGASTRIC BALLOONS MARKET BY COUNTRY, 2017-2023, (IN $MILLION)
2. ESTIMATE OF BARIATRIC SURGERY NUMBERS IN THE US (2011-2015)
3. COST OF WEIGHT-LOSS SURGERIES IN THE US V/S INDIA IN $
4. CHANGES IN VOLUME OF DIFFERENT TYPES OF BARIATRIC PROCEDURES PERFORMED IN CANADIAN HOSPITALS (2006–2007 TO 2013–2014)
5. US INTRAGASTRIC BALLOONS MARKET, 2017-2023 (IN $MILLION)
6. CANADA INTRAGASTRIC BALLOONS MARKET, 2017-2023 (IN $MILLION)
7. BRAZIL INTRAGASTRIC BALLOONS MARKET, 2017-2023 (IN $MILLION)
8. REST OF AMERICAS INTRAGASTRIC BALLOONS MARKET, 2017-2023 (IN $MILLION)
FIGURE LIST
1. MARKET SIZE ESTIMATION
2. DATA TRIANGULATION
3. VALUE CHAIN ANALYSIS
4. AMERICAS MARKET SHARE, BY COUNTRY, 2017
5. US FOOD CONSUMPTION AS % OF CALORIES
6. PREVALENCE OF OBESITY IN THE US ADULTS AGED BETWEEN 20 TO
7. TRENDS IN OVERWEIGHT AND OBESITY RATES, BY EDUCATION LEVEL IN THE US
8. US INTRAGASTRIC BALLOONS MARKET, 2017-2023 (IN $MILLION)
9. PERCENTAGE OF OBESE POPULATION (SELF-REPORTED) IN CANADA 2014
10. TRENDS IN OVERWEIGHT AND OBESITY RATES, BY EDUCATION LEVEL IN CANADA
11. CANADA INTRAGASTRIC BALLOONS MARKET, 2017-2023 (IN $MILLION)
12. BRAZIL INTRAGASTRIC BALLOONS MARKET, 2017-2023 (IN $MILLION)
13. LATIN AMERICA: WORST OBESITY SCENARIO AMONG EMERGING COUNTRIES BY 2030
14. TRENDS IN OVERWEIGHT AND OBESITY RATES, BY EDUCATION LEVEL IN MEXICO
15. REST OF AMERICAS INTRAGASTRIC BALLOONS MARKET, 2017-2023 (IN $MILLION)
